Pitavastatin Further Decreases Serum High-Sensitive C-Reactive Protein Levels in Hypertensive Patients with Hypercholesterolemia Treated with Angiotensin II, Type-1 Receptor Antagonists

By Yoshika Masamichi   Komiyama Yutaka   Masuda Midori   Yokoi Toyohiko   Masaki Hiroya   Ohkura Hiroe   Takahashi Hakuo  

Clinical and Experimental Hypertension, Vol. 32, Iss. 6, 2010-10 ,pp. : 341-346

Informa Healthcare

Access to resources Recommend Favorite

The Type I Angiotensin II Receptor Couples to Stat1 and Stat3 Activation Through Jak2 Kinase in Neonatal Rat Cardiac Myocytes

By McWhinney C.D.   Hunt R.A.   Conrad K.M.   Dostal D.E.   Baker K.M.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 9, 1997-09 ,pp. : 2513-2524

Academic Press

Access to resources Recommend Favorite

Expression of Angiotensin II Receptor Type 1 Is Reduced in Advanced Rat Liver Fibrosis

By Töx Ulrich   Scheller Ingo   Kociok Norbert   Kern Michael   Klanac Dejan   Daudi Sharif   Laue Oliver   Schirmacher Peter   Goeser Tobias   Schulte Sigrid   Steffen Hans  

Digestive Diseases and Sciences, Vol. 52, Iss. 8, 2007-08 ,pp. : 1995-2005

Springer Publishing Company

Access to resources Recommend Favorite

Recent Progress in Signal Transduction Research of the Angiotensin II Type-1 Receptor: Protein Kinases, Vascular Dysfunction and Structural Requirement

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 4, 2005-10 ,pp. : 305-322

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure

By Nakamura T.   Sugaya T.   Koide H.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 490-492

Springer Publishing Company

Access to resources Recommend Favorite